Clinical trials recruiting in Elizabeth, New Jersey
9
Recruiting trials
15
Conditions
Phase breakdown
Phase 2 5Phase 3 4Phase 4 1
Conditions recruiting in Elizabeth, New Jersey
Recruiting trials in Elizabeth, New Jersey
- ATATcH Alternating Treatment Plans for Advanced Cancer
- Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
- Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
- Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
- Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
- Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
Common questions
How many clinical trials are recruiting in Elizabeth, New Jersey?
9 recruiting trials have at least one study site in Elizabeth, New Jersey.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.